Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 27, 2017

DrugPatentWatch Database Preview

Oxcarbazepine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for oxcarbazepine and what is the scope of patent protection?

Oxcarbazepine
is the generic ingredient in three branded drugs marketed by Taro, Glenmark Generics, Ani Pharms Inc, Supernus Pharms, Novartis, Sun Pharm Inds Ltd, Cadista Pharms, Apotex Inc, Amneal Pharms, Breckenridge Pharm, West-ward Pharms Int, and Sun Pharm Inds, and is included in fourteen NDAs. There are ten patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Oxcarbazepine has fifty-seven patent family members in thirty-four countries.

There are eighteen drug master file entries for oxcarbazepine. Twenty-eight suppliers are listed for this compound.

Summary for Generic Name: oxcarbazepine

Tradenames:3
Patents:10
Applicants:12
NDAs:14
Drug Master File Entries: see list18
Suppliers / Packagers: see list28
Bulk Api Vendors: see list59
Clinical Trials: see list14
Patent Applications: see list4,376
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:oxcarbazepine at DailyMed

Pharmacology for Ingredient: oxcarbazepine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds
OXCARBAZEPINE
oxcarbazepine
TABLET;ORAL077794-002Oct 9, 2007ABRXNoNo► Subscribe► Subscribe
Supernus Pharms
OXTELLAR XR
oxcarbazepine
TABLET, EXTENDED RELEASE;ORAL202810-003Oct 19, 2012RXYesYes9,370,525► SubscribeY ► Subscribe
Sun Pharm Inds
OXCARBAZEPINE
oxcarbazepine
TABLET;ORAL077794-003Oct 9, 2007ABRXNoNo► Subscribe► Subscribe
Apotex Inc
OXCARBAZEPINE
oxcarbazepine
TABLET;ORAL077747-003Apr 9, 2008ABRXNoNo► Subscribe► Subscribe
Novartis
TRILEPTAL
oxcarbazepine
SUSPENSION;ORAL021285-001May 25, 2001ABRXYesYes7,037,525*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot